Weekly NIH Funding Opportunities and Notices NIH Guide for Grants and Contracts June 22, 2018 Table of Contents (TOC) Web Version

Transcription

1 Weekly NIH Funding Opportunities and Notices NIH Guide for Grants and Contracts June 22, 2018 Table of Contents (TOC) Web Version Notices Clarification: Assignment Deadlines for Applications Submitted Under the NIH Continuous Submission Policy (NOT-OD ) Office of the Director, NIH Notice of Correction to NOT-OD "Notice of Intent to Publish a Funding Opportunity Announcement for the Predoctoral Training in Advanced Data Analytics for Behavioral and Social Sciences Research (BSSR) Institutional Research Training Program [T32]" (NOT-OD ) Office of the Director, NIH Notice of Availability of Administrative Supplements for NIH Grants that are NOT Focused on Down Syndrome to Address Specific Down Syndrome Research Objectives (NOT-OD ) Office of the Director, NIH National Center for Complementary and Integrative Health National Heart, Lung, and Blood Institute National Institute of Diabetes and Digestive and Kidney Diseases National Institute of General Medical Sciences National Institute of Nursing Research

2 Notice of Availability of Administrative Supplements for NIH Grants Focused on Down Syndrome to Address Specific Down Syndrome Research Objectives (NOT-OD ) Office of the Director, NIH National Heart, Lung, and Blood Institute National Institute of Diabetes and Digestive and Kidney Diseases National Institute of General Medical Sciences National Institute of Nursing Research Notice to Extend the Expiration Date for PAR "Emerging Directions for Addressing Health Disparities in Alzheimer's Disease (R03)" (NOT-AG ) Notice to Extend the Expiration Date for PAR "Understanding Alzheimer's Disease in the Context of the Aging Brain (R01)" (NOT-AG ) Notice to Extend the Expiration Date for PAR "Novel Approaches to Diagnosing Alzheimer's Disease & Predicting Progression (R01)" (NOT-AG ) Notice to Extend the Expiration Date for PAR "Research on Informal and Formal Caregiving for Alzheimer's Disease (R01 Clinical Trial Optional)" (NOT-AG ) Notice to Extend the Expiration Date for PAR "Research on Informal and Formal Caregiving for Alzheimer's Disease (R21 Clinical Trial Optional)" (NOT-AG ) Notice of Clarification of NIA intent to fund awards for RFA-HL "Stimulating Access to Research in Residency (StARR) (R38)"

3 (NOT-AG ) Notice of Change to Eligible Organizations in NIAID PAR Global Infectious Disease Research Administration Development Award for Low-and Middle-Income Country Institutions (G11 Clinical Trial Not Allowed) (NOT-AI ) Request for Information (RFI): Evaluation of the NIH Senator Paul D. Wellstone Muscular Dystrophy Research Centers Program (NOT-AR ) National Institute of Arthritis and Musculoskeletal and Skin Diseases National Heart, Lung, and Blood Institute Notice of Addition of Letter of Intent Due Dates on BRAIN Initiative: Theories, Models and Methods for Analysis of Complex Data from the Brain (R01 Clinical Trial Not Allowed) (NOT-EB ) National Institute of Biomedical Imaging and Bioengineering Strengthen Regulatory Systems to Ensure the Safety and Quality of Food and Medical Products (U01) (NOT-FD ) Food and Drug Administration Strengthening Global Competency and Capacity in Inspectional Approaches and Good Manufacturing Practices (GMP) (U01) (NOT-FD ) Food and Drug Administration Notice of U.S. Department of Agriculture (USDA) Participation in PAR Comparative Genomics Research Program (R01) (NOT-HG ) Notice of NIMH's Interest in Studies of Neural Circuitry Linked to Computationally-Defined Behaviors of Relevance to Psychiatry in Rodents and Non-Human Primates (NOT-MH ) Notice of Clarification for Submission of Materials Related to Communications with the FDA for RFA-NS "Translational Neural Devices (UG3/UH3 Clinical Trial Required)" (NOT-NS ) RFA-NS "Translational Neural Devices (U44 Clinical Trial Required)" (NOT-NS )

4 RFA-NS "BRAIN Initiative: Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System (UG3/UH3)" (NOT-NS ) RFA-NS "BRAIN Initiative: Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System (U44)" (NOT-NS ) RFA-NS "BRAIN Initiative: Clinical Studies to Advance Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System" (NOT-NS ) Notice Regarding New Applications for PAR : "Occupational Safety and Health Education and Research Centers (42)" (NOT-OH ) Centers for Disease Control and Prevention Notice of Pre-Submission Webinars for RFA-TR : Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN) (U54 Clinical Trial Optional) and RFA-TR : Data Management and Coordinating Center (DMCC) (NOT-TR ) Requests for Applications High-Priority Behavioral and Social Research Networks (R24 Clinical Trial Not Allowed) (RFA-AG ) Application Receipt Date(s): February 1, 2019, by 5:00 PM local time of applicant organization. All types of non-aids applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. High-Priority Behavioral and Social Research Networks in Alzheimer's Disease and Alzheimer's Disease Related Dementias (R24 Clinical Trial Not Allowed) (RFA-AG ) Application Receipt Date(s): February 1, 2019, by 5:00 PM local time of applicant organization. All types of non-aids applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement.

5 Modeling and Simulation to Optimize HIV Prevention Research (MS OPR) (R01 Clinical Trial not allowed) (RFA-AI ) Application Receipt Date(s): December 13, 2018, by 5:00 PM local time of applicant organization. All types of non-aids applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Collaborative Human Tissue Network (CHTN) (UM1 Clinical Trials Not Allowed) (RFA-CA ) Application Receipt Date(s): August 28, 2018, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this FOA. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Program Announcements Administrative Supplements to Promote Diversity in Small Businesses-SBIR/STTR (Admin Supp Clinical Trial Not Allowed) (PA ) Office of the Director, NIH National Center for Complementary and Integrative Health National Institute on Alcohol Abuse and Alcoholism National Institute of Biomedical Imaging and Bioengineering National Institute on Drug Abuse National Institute of General Medical Sciences National Institute of Nursing Research Application Receipt/Submission Date(s): Applications are accepted on a rolling basis at any time starting 30 days after the Open Date until the expiration date, unless otherwise noted in Institute specific language. Please consult with Scientific contacts listed in Section VII.

6 Enhancing Developmental Biology Research at Academic Research Enhancement Award Eligible Institutions (R15 - Clinical Trial Not Allowed) (PAR ) Application Receipt/Submission Date(s): September 18, 2018, September 18, 2019, September 18, 2020, by 5:00 PM local time of applicant organization. All types of non-aids applications allowed for this funding opportunity announcement are due on these dates. Global Brain and Nervous System Disorders Research Across the Lifespan (R01 Clinical Trials Optional) (PAR ) John E. Fogarty International Center Application Receipt/Submission Date(s): November 7, 2018; November 7, 2019,by 5:00 PM local time of applicant organization. All types of non-aids applications allowed for this funding opportunity announcement are due on these dates. Global Brain and Nervous System Disorders Research Across the Lifespan (R21 Clinical Trial Optional) (PAR ) John E. Fogarty International Center Application Receipt/Submission Date(s): November 7, 2018; November 7, 2019), by 5:00 PM local time of applicant organization. All types of non-aids applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * You have received this information as a result of being subscribed to the UTHSCSA Office of Sponsored Programs fundinginfo2 ListServ. To remove yourself from this list, visit the Subscriber's Corner in the List Archives and follow the onscreen instructions to log in and manage your list subscriptions. * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *